Wealth Effects LLC Amgen Inc Transaction History

Wealth Effects LLC

  • $255 Million
  • Q3 2024

A detailed history of Wealth Effects LLC transactions in Amgen Inc stock. As of the latest transaction made, Wealth Effects LLC holds 2,710 shares of AMGN stock, worth $716,767. This represents 0.34% of its overall portfolio holdings.

Number of Shares
2,710
Previous 2,709 0.04%
Holding current value
$716,767
Previous $846,000 3.19%
% of portfolio
0.34%
Previous 0.35%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024
BUY
$309.38 - $337.38 $309 - $337
1 Added 0.04%
2,710 $873,000
Q2 2024

Aug 02, 2024
BUY
$262.75 - $319.31 $262 - $319
1 Added 0.04%
2,709 $846,000
Q4 2023

Jan 29, 2024
BUY
$255.7 - $288.46 $255 - $288
1 Added 0.04%
2,708 $779,000
Q3 2023

Oct 16, 2023
BUY
$218.65 - $271.46 $218 - $271
1 Added 0.04%
2,707 $727,000
Q2 2023

Jul 18, 2023
SELL
$214.27 - $253.37 $15,855 - $18,749
-74 Reduced 2.66%
2,706 $600,000
Q1 2023

May 04, 2023
BUY
$225.79 - $275.2 $225 - $275
1 Added 0.04%
2,780 $672,000
Q4 2022

Feb 02, 2023
SELL
$229.03 - $291.01 $45,576 - $57,910
-199 Reduced 6.68%
2,779 $729,000
Q3 2022

Nov 14, 2022
BUY
$224.46 - $253.15 $224 - $253
1 Added 0.03%
2,978 $671,000
Q2 2022

Aug 03, 2022
BUY
$230.71 - $256.74 $230 - $256
1 Added 0.03%
2,977 $724,000
Q1 2022

May 16, 2022
SELL
$219.27 - $242.57 $32,890 - $36,385
-150 Reduced 4.8%
2,976 $720,000
Q4 2021

Feb 09, 2022
BUY
$198.88 - $227.6 $621,698 - $711,477
3,126 New
3,126 $703,000

Others Institutions Holding AMGN

# of Institutions
3,125
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Wealth Effects LLC Portfolio

Follow Wealth Effects LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Effects LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Effects LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email